GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) will post its quarterly earnings results before the market opens on Tuesday, April 30th. Analysts expect GE HealthCare Technologies to post earnings of $0.90 per share for the quarter. GE HealthCare Technologies has set its FY 2024 guidance at 4.200-4.350 EPS and its FY24 guidance at $4.20-$4.35 EPS.Individual that wish to register for the company’s earnings conference call can do so using this link.
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last posted its quarterly earnings results on Tuesday, February 6th. The company reported $1.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.07 by $0.11. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. The company had revenue of $5.20 billion for the quarter, compared to analyst estimates of $5.09 billion. During the same quarter last year, the company earned $1.31 EPS. GE HealthCare Technologies’s revenue for the quarter was up 5.3% compared to the same quarter last year. On average, analysts expect GE HealthCare Technologies to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.
GE HealthCare Technologies Stock Performance
Shares of GE HealthCare Technologies stock opened at $86.24 on Friday. The business has a 50-day simple moving average of $88.92 and a 200-day simple moving average of $78.52. The company has a debt-to-equity ratio of 1.18, a quick ratio of 0.83 and a current ratio of 1.05. GE HealthCare Technologies has a one year low of $62.35 and a one year high of $94.50. The company has a market cap of $39.35 billion, a PE ratio of 28.56, a P/E/G ratio of 2.99 and a beta of 0.94.
GE HealthCare Technologies Dividend Announcement
Wall Street Analyst Weigh In
A number of equities research analysts have recently weighed in on GEHC shares. Mizuho raised their price objective on shares of GE HealthCare Technologies from $96.00 to $110.00 and gave the company a “buy” rating in a report on Thursday, April 11th. Citigroup lifted their price target on GE HealthCare Technologies from $88.00 to $103.00 and gave the stock a “buy” rating in a report on Wednesday, April 3rd. Argus increased their price objective on GE HealthCare Technologies from $80.00 to $110.00 and gave the company a “buy” rating in a report on Monday, April 1st. Evercore ISI raised their target price on GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an “outperform” rating in a research report on Thursday, April 4th. Finally, UBS Group raised GE HealthCare Technologies from a “sell” rating to a “neutral” rating and upped their price target for the company from $66.00 to $88.00 in a report on Monday, February 12th. Four analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $95.09.
Check Out Our Latest Stock Analysis on GEHC
GE HealthCare Technologies Company Profile
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Further Reading
- Five stocks we like better than GE HealthCare Technologies
- How to Calculate Retirement Income: MarketBeat’s Calculator
- MarketBeat Week in Review – 4/22 – 4/26
- Retail Stocks Investing, Explained
- 3 Stocks Leading the U.S. Agriculture Comeback
- The 3 Best Fintech Stocks to Buy Now
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.